203 related articles for article (PubMed ID: 12763926)
1. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
Deaglio S; Capobianco A; Bergui L; Dürig J; Morabito F; Dührsen U; Malavasi F
Blood; 2003 Sep; 102(6):2146-55. PubMed ID: 12763926
[TBL] [Abstract][Full Text] [Related]
2. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
Deaglio S; Vaisitti T; Bergui L; Bonello L; Horenstein AL; Tamagnone L; Boumsell L; Malavasi F
Blood; 2005 Apr; 105(8):3042-50. PubMed ID: 15613544
[TBL] [Abstract][Full Text] [Related]
3. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
[TBL] [Abstract][Full Text] [Related]
5. CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow.
Jaksic O; Paro MM; Kardum Skelin I; Kusec R; Pejsa V; Jaksic B
Blood; 2004 Mar; 103(5):1968-9. PubMed ID: 14976064
[No Abstract] [Full Text] [Related]
6. CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL.
Pittner BT; Jelinek DF; Kay NE
Leukemia; 2004 Jan; 18(1):180-2. PubMed ID: 14523466
[No Abstract] [Full Text] [Related]
7. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.
Zupo S; Isnardi L; Megna M; Massara R; Malavasi F; Dono M; Cosulich E; Ferrarini M
Blood; 1996 Aug; 88(4):1365-74. PubMed ID: 8695855
[TBL] [Abstract][Full Text] [Related]
8. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
[TBL] [Abstract][Full Text] [Related]
9. CD38 modifications in chronic lymphocytic leukemia: are they relevant?
Ghia P; Guida G; Scielzo C; Geuna M; Caligaris-Cappio F
Leukemia; 2004 Oct; 18(10):1733-5. PubMed ID: 15343349
[No Abstract] [Full Text] [Related]
10. Quantification of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL): a comparison between antibody binding capacity (ABC) and relative median fluorescence (RMF).
Dignum HM; Summerfield GP; Proctor SJ; Mainou-Fowler T
Leuk Lymphoma; 2004 Jun; 45(6):1167-73. PubMed ID: 15359996
[TBL] [Abstract][Full Text] [Related]
11. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
[TBL] [Abstract][Full Text] [Related]
12. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Dignum H; Taylor PR; Dickinson AM; Saunders PW; Proctor SJ; Summerfield GP
Br J Haematol; 2002 Sep; 118(3):755-61. PubMed ID: 12181042
[TBL] [Abstract][Full Text] [Related]
13. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipid microdomains mediate CD38 internalization: topography of the endocytosis.
Trubiani O; Guarnieri S; Orciani M; Salvolini E; Di Primio R
Int J Immunopathol Pharmacol; 2004; 17(3):293-300. PubMed ID: 15461863
[TBL] [Abstract][Full Text] [Related]
17. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
[TBL] [Abstract][Full Text] [Related]
19. CD38 expression on B-cell chronic lymphocytic leukemic cells is strongly correlated with vascular endothelial growth factor expression.
McCabe D; Bacon L; O'Regan K; Condron C; O'Donnell JR; Murphy PT
Leukemia; 2004 Mar; 18(3):649-50. PubMed ID: 14749705
[No Abstract] [Full Text] [Related]
20. Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia.
Manna A; Aulakh S; Jani P; Ahmed S; Akhtar S; Coignet M; Heckman M; Meghji Z; Bhatia K; Sharma A; Sher T; Alegria V; Malavasi F; Chini EN; Chanan-Khan A; Ailawadhi S; Paulus A
Clin Cancer Res; 2019 Jul; 25(13):3974-3985. PubMed ID: 30940652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
